Sorry, you need to enable JavaScript to visit this website.

XALKORI (crizotinib) Health Professional Information

Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve. Click here to learn how we are responding.
Pfizer reconnaît les préoccupations du grand public concernant la situation liée à la COVID-19, qui continue d'évoluer. Cliquez ici pour savoir comment nous avons réagi.

Health Professional Information

SUMMARY PRODUCT INFORMATION

Route of Administration

Dosage Form / Strength

All Nonmedicinal Ingredients

Oral

capsules 200 mg and 250 mg

No clinically relevant nonmedicinal ingredients.

For a complete listing see Dosage Forms, Composition and Packaging section.

What's New

No Current Announcements.

Contact Pfizer Medical Information

Report an Adverse Event
1 866 723-7111